520 related articles for article (PubMed ID: 30045991)
1. Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice.
Broecker F; Liu STH; Sun W; Krammer F; Simon V; Palese P
J Virol; 2018 Oct; 92(20):. PubMed ID: 30045991
[TBL] [Abstract][Full Text] [Related]
2. The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sex.
Martínez JL; Lemus N; Lai TY; Mishra M; González-Domínguez I; Puente-Massaguer E; Loganathan M; Francis B; Samanovic MI; Krammer F; Mulligan MJ; Simon V; Palese P; Sun W
Vaccine; 2024 May; 42(14):3365-3373. PubMed ID: 38627145
[TBL] [Abstract][Full Text] [Related]
3. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
[TBL] [Abstract][Full Text] [Related]
4. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
[TBL] [Abstract][Full Text] [Related]
5. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
[TBL] [Abstract][Full Text] [Related]
6. The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus.
Abente EJ; Santos J; Lewis NS; Gauger PC; Stratton J; Skepner E; Anderson TK; Rajao DS; Perez DR; Vincent AL
J Virol; 2016 Sep; 90(18):8266-80. PubMed ID: 27384658
[TBL] [Abstract][Full Text] [Related]
7. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
[TBL] [Abstract][Full Text] [Related]
8. Antibody Responses toward the Major Antigenic Sites of Influenza B Virus Hemagglutinin in Mice, Ferrets, and Humans.
Sun W; Kang DS; Zheng A; Liu STH; Broecker F; Simon V; Krammer F; Palese P
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381487
[TBL] [Abstract][Full Text] [Related]
9. Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.
Wang X; Ilyushina NA; Lugovtsev VY; Bovin NV; Couzens LK; Gao J; Donnelly RP; Eichelberger MC; Wan H
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807224
[TBL] [Abstract][Full Text] [Related]
10. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
[TBL] [Abstract][Full Text] [Related]
11. Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes.
Chiba S; Kong H; Neumann G; Kawaoka Y
mBio; 2023 Aug; 14(4):e0062223. PubMed ID: 37466314
[TBL] [Abstract][Full Text] [Related]
12. A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head.
Benjamin E; Wang W; McAuliffe JM; Palmer-Hill FJ; Kallewaard NL; Chen Z; Suzich JA; Blair WS; Jin H; Zhu Q
J Virol; 2014 Jun; 88(12):6743-50. PubMed ID: 24696468
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity.
Kirkpatrick E; Henry C; McMahon M; Jiang K; Strohmeier S; van Bakel H; Wilson PC; Krammer F
J Virol; 2020 Nov; 94(23):. PubMed ID: 32907980
[TBL] [Abstract][Full Text] [Related]
14. Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses.
Popova L; Smith K; West AH; Wilson PC; James JA; Thompson LF; Air GM
PLoS One; 2012; 7(7):e41895. PubMed ID: 22848649
[TBL] [Abstract][Full Text] [Related]
15. Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection.
DeDiego ML; Anderson CS; Yang H; Holden-Wiltse J; Fitzgerald T; Treanor JJ; Topham DJ
Immunology; 2016 Jun; 148(2):160-73. PubMed ID: 26854888
[TBL] [Abstract][Full Text] [Related]
16. Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes.
Smith G; Liu Y; Flyer D; Massare MJ; Zhou B; Patel N; Ellingsworth L; Lewis M; Cummings JF; Glenn G
Vaccine; 2017 Sep; 35(40):5366-5372. PubMed ID: 28844407
[TBL] [Abstract][Full Text] [Related]
17. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins.
Wang TT; Tan GS; Hai R; Pica N; Petersen E; Moran TM; Palese P
PLoS Pathog; 2010 Feb; 6(2):e1000796. PubMed ID: 20195520
[TBL] [Abstract][Full Text] [Related]
18. Substitutions near the hemagglutinin receptor-binding site determine the antigenic evolution of influenza A H3N2 viruses in U.S. swine.
Lewis NS; Anderson TK; Kitikoon P; Skepner E; Burke DF; Vincent AL
J Virol; 2014 May; 88(9):4752-63. PubMed ID: 24522915
[TBL] [Abstract][Full Text] [Related]
19. Generation and characterization of monoclonal antibodies against the hemagglutinin of H3N2 influenza A viruses.
Yang F; Zhu L; Liu F; Cheng L; Yao H; Wu N; Wu H; Li L
Virus Res; 2022 Aug; 317():198815. PubMed ID: 35595011
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Next-Generation H3 Influenza Vaccines in Ferrets Pre-Immune to Historical H3N2 Viruses.
Allen JD; Ross TM
Front Immunol; 2021; 12():707339. PubMed ID: 34475872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
